logo
Plus   Neg
Share
Email

Lilis Energy Files For Chapter 11 Bankruptcy - Quick Facts

Lilis Energy, Inc. (LLEX) announced Monday that it has filed petitions under Chapter 11 of the United States Bankruptcy Code to initiate voluntary cases in the United States Bankruptcy Court for the Southern District of Texas, Houston Division.

Lilis Energy is an exploration and production company operating in the Permian Basin of West Texas and Southeastern New Mexico.

The Chapter 11 petitions were filed in accordance with a Restructuring Support Agreement (RSA) entered into among the Company and certain of its subsidiaries, certain investment funds and entities affiliated with Värde Partners, Inc., which collectively own all of the Company's outstanding preferred stock and debt.

Under the RSA, the companies have agreed to support a restructuring of Lilis Energy and its subsidiaries under a Chapter 11 plan of reorganization. This is expected to reduce the Company's funded debt obligations by more than $34.9 million, and right-size the Company's bank indebtedness for future operations.

The Company expects to continue to operate in the ordinary course throughout the restructuring process without material disruption to vendors, suppliers and partners.

The Plan is contingent upon the Värde Funds' election to provide, on or before August 17, 2020, an agreed equity commitment and provision of additional debtor-in-possession (DIP) financing. Otherwise, the Company will pursue an agreed sales process with respect to its assets.

With the filing, and subject to court approval, the Company has received a commitment from its bank lenders under its Credit Agreement to provide up to $15.0 million in DIP financing. The Company anticipates up to $5.0 million will be available on an interim basis.

On June 27, 2020, Markus Specks resigned as a director of the Company and was replaced by Nicholas Winter, a Managing Director of Värde Partners, Inc., as their new designated director.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
The U.S. Food and Drug Administration granted emergency use authorization (EUA) for the first and only clinical T cell-based test for patients to detect the unique T-cell signature specific to SARS-CoV-2, the virus that causes COVID-19. The test confirms recent or prior COVID-19 infection. Developed by Adaptive Biotechnologies, T-Detect COVID Test is a next generation sequencing based (NGS) test. AstraZeneca's one batch of Covid vaccine has been suspended by Austrian health authorities following reports of a death and an illness after receiving vaccination, reports said. The issues were reported in the district clinic of Zwettl in Lower Austria province. The Federal Office for Safety in Health Care in the country said the remaining stocks of the affected AstraZeneca/Oxford Covid-19 vaccine DuPont (DD) announced Monday that it has agreed to acquire Laird Performance Materials from with private equity firm Advent International for $2.3 billion. The company will use existing cash balances for the acquisition. The transaction is expected to close in the third quarter of 2021, subject to regulatory...
Follow RTT